Company Filing History:
1 out of 9 
1 out of 154 
1 out of 5,089 
Years Active: 2020
Title: Lorenzo Tibaldi: Innovator in Lentiviral Vector Technology
Introduction
Lorenzo Tibaldi is a notable inventor based in Paris, France. He has made significant contributions to the field of biotechnology, particularly in the development of lentiviral vectors for therapeutic applications. His innovative work focuses on enhancing the regulated expression of chimeric antigen receptor (CAR) molecules, which are crucial for advancing cancer treatment.
Latest Patents
Lorenzo Tibaldi holds a patent for "Lentiviral vectors for regulated expression of a chimeric antigen receptor molecule." This invention pertains to the regulated expression of a CAR within a lentiviral vector. The CAR includes a hook-binding domain that interacts with a hook, preferably encoded by the same lentiviral vector, which prevents proper processing and release of the CAR to the cell membrane. The invention encompasses vectors, methods of making the vectors, and methods of using them, including medicinal uses. These vectors can be administered to humans to induce immune responses and treat cancers and tumors. He has 1 patent to his name.
Career Highlights
Throughout his career, Lorenzo has worked with prominent organizations in the biotechnology sector. Notable companies include Theravectys and Institut Curie, where he has contributed to groundbreaking research and development efforts. His work has been instrumental in advancing the understanding and application of lentiviral vectors in medicine.
Collaborations
Lorenzo has collaborated with several talented individuals in his field, including Sophie Agaugue and Klervi Even-Desrumaux. These partnerships have fostered innovation and have been vital in the progression of his research endeavors.
Conclusion
Lorenzo Tibaldi's contributions to the field of biotechnology, particularly through his patent on lentiviral vectors, highlight his role as an innovator in cancer treatment. His work continues to influence the development of therapeutic strategies aimed at improving patient outcomes.